PART I Overview Organon & Co. (Organon, the Company, we, our, or us) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across womens health and general medicines, which includes biosimilars, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 countries and territories. We sell thes...
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0001628280-26-011125 | EDGAR | 75K words |
| 2025-02-28 | 2024-12-31 | 0001821825-25-000006 | EDGAR | — |
| 2024-02-26 | 2023-12-31 | 0001628280-24-006733 | EDGAR | — |
| 2023-02-27 | 2022-12-31 | 0001821825-23-000003 | EDGAR | — |
| 2022-03-21 | 2021-12-31 | 0001821825-22-000002 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001628280-25-050795 | EDGAR | 26K words |
| 2025-08-06 | 2025-06-30 | 0001821825-25-000066 | EDGAR | — |
| 2025-05-02 | 2025-03-31 | 0001821825-25-000023 | EDGAR | — |
| 2024-11-01 | 2024-09-30 | 0001821825-24-000108 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001821825-24-000083 | EDGAR | — |
| 2024-05-03 | 2024-03-31 | 0001821825-24-000056 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001821825-23-000013 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001821825-23-000010 | EDGAR | — |
| 2023-05-05 | 2023-03-31 | 0001821825-23-000006 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001821825-22-000012 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0001821825-22-000009 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0001821825-22-000006 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-20 | 0001104659-26-017870 | EDGAR | 1K words |
| 2026-02-12 | 0001104659-26-013888 | EDGAR | — |
| 2025-11-10 | 0001104659-25-108821 | EDGAR | — |
| 2025-11-07 | 0001104659-25-108130 | EDGAR | — |
| 2025-10-27 | 0001104659-25-102324 | EDGAR | — |
| 2025-08-05 | 0001104659-25-073929 | EDGAR | — |
| 2025-06-12 | 0001104659-25-058900 | EDGAR | — |
| 2025-05-27 | 0001104659-25-052994 | EDGAR | — |
| 2025-05-01 | 0001104659-25-043023 | EDGAR | — |
| 2025-04-15 | 0001104659-25-035173 | EDGAR | — |
69 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001821825 |
| Ticker | OGN |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.organon.com |
| Listed | 2021-05-14 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report